Stifel Financial’s NanoViricides NNVC Stock Holding History

Stifel Financial’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-21,200	Closed	-$24.8K	–	3548
2025 Q1	$24.8K	Hold	21,200	–	–	﹤0.01%	3382
2024 Q4	$30.3K	Hold	21,200	–	–	﹤0.01%	3338
2024 Q3	$31.8K	Hold	21,200	–	–	﹤0.01%	3321
2024 Q2	$36.5K	Hold	21,200	–	–	﹤0.01%	3297
2024 Q1	$24.6K	Hold	21,200	–	–	﹤0.01%	3300
2023 Q4	$21.6K	Hold	21,200	–	–	﹤0.01%	3267
2023 Q3	$28.4K	Hold	21,200	–	–	﹤0.01%	3224
2023 Q2	$24.4K	Buy	21,200 +9,700	+84%	+$11.7K	﹤0.01%	3276
2023 Q1	$13.5K	Buy	+11,500	New	+$15.5K	﹤0.01%	3302

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stifel Financial's NNVC Position: Q2 2025 in Review

Stifel Financial sold out of NanoViricides (NNVC) in Q2 2025, closing a stake of 21,200 shares — an estimated $24.8K sold.

Stifel Financial first reported a position in NNVC in Q1 2023 and held it in 9 quarters. The position peaked at $36.5K in Q2 2024. 33 funds tracked by Wall St. Rank hold NNVC as of Q2 2025.

Stifel Financial reported no remaining NanoViricides position as of Q2 2025 after selling out during the quarter.
Stifel Financial sold 21,200 NanoViricides shares in Q2 2025, an estimated $24.8K.
Stifel Financial first reported a position in NanoViricides in Q1 2023 and held it in 9 quarters.
Stifel Financial's NanoViricides position peaked at $36.5K in Q2 2024.
33 funds tracked by Wall St. Rank held NanoViricides as of Q2 2025.

Based on Stifel Financial's 13F filing for Q2 2025, filed 14 Aug 2025.